Boston Scientific Comments On Swedish Registry Results
Tue, 13 Feb 2007 08:00 AM EST
... Boston Scientific Corporation (NYSE: BSX) today commented on results from a Swedish registry assessing the long-term outcomes of drug-eluting stents (DES) versus bare- metal stents (BMS) that were released online today and are scheduled for publication in the March 8th edition of the New England Journal of Medicine. [click link for full article] ...
Related Topics
- Immunization Registry
- Acute intermittent porphyria
- Tularemia
- Bone Marrow
- Clozapine
- Western/Clinical Treatment and Therapy
- Child Abuse And Neglect
- Births, Deaths & Marriages
- Aphasia
- Pollen
- CK
- Botulism
- Childhood Immunization
- Healer
- Pseudoephedrine
- Noise
- Ophthalmology
- Adapalene Topical
- Whooping Cough
- Smallpox

Not Signed In -


